Alpha Tau Medical (DRTS) Long-Term Deferred Tax (2020 - 2025)
Alpha Tau Medical (DRTS) posted Long-Term Deferred Tax of $97000.0 for Q4 2025, down 97.45% sequentially from $3.8 million in Q4 2021.
Analysis
Alpha Tau Medical (DRTS) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends
Alpha Tau Medical has reported Long-Term Deferred Tax for 3 years, with the latest figure at $97000.0 in Q4 2025.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $97000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $97000.0 (changed N/A YoY) and the FY2025 annual result came in at $97000.0, changed N/A from the prior year.
- Long-Term Deferred Tax slipped to $97000.0 in Q4 2025 per DRTS's latest filing, from $3.8 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $3.8 million in Q4 2021 and troughed at $97000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.21 Bn | 1.11 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2021 | 3.80 Mn |
| Dec 31, 2020 | 2.23 Mn |